The global diabetes devices market was valued at USD 20.92 billion in 2018 and is expected to grow to USD 48.35 billion by 2032, with a compound annual growth rate (CAGR) of 6.2% throughout the forecast period. In 2018, North America led the market, holding a share of 40.54%.

The diabetes devices market is expanding steadily as the global prevalence of diabetes continues to rise. These devices play a crucial role in monitoring blood glucose levels and delivering insulin, helping patients manage their condition more effectively. The market includes a range of products such as blood glucose monitors, continuous glucose monitoring systems, insulin pumps, and pens. Technological advancements, growing patient awareness, and the adoption of digital health solutions are contributing to the increased demand for diabetes devices. However, high costs, limited access in low-income regions, and regulatory challenges act as barriers to widespread adoption. Despite these challenges, the diabetes devices market is expected to grow significantly across various regions, driven by innovation and increasing healthcare investments.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/diabetes-devices-market-100803**

Market Segmentation

• By product type, the diabetes devices market is segmented into blood glucose monitoring devices (self-monitoring blood glucose systems, continuous glucose monitoring systems) and insulin delivery devices (insulin pens, insulin pumps, jet injectors).
• By end user, the market is segmented into hospitals, homecare settings, and diagnostic centers.
• Based on distribution channels, it is divided into hospital pharmacies, retail pharmacies, and online sales platforms.
• The wearable segment within continuous glucose monitors is gaining traction due to user convenience and real-time tracking capabilities.
• Insulin pens continue to dominate the insulin delivery category due to their ease of use and lower cost compared to insulin pumps in the diabetes devices market.

List Of Key Companies Covered in Diabetes Devices Market:

• Hoffmann-La Roche Ltd
• Tandem Diabetes Care, Inc.
• Braun Melsungen AG
• Medtronic
• BD
• Novo Nordisk A/S
• Abbott
• Sanofi